Pharmaceutical News RSS Feed - Pharmaceutical News

Lisinopril oral solution approved for treatment of hypertension in children and adults

Lisinopril oral solution approved for treatment of hypertension in children and adults

Silvergate Pharmaceuticals, Inc., leader in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Qbrelis (Lisinopril) Oral Solution, the first and only FDA-approved Lisinopril oral solution. [More]
Kaiser Permanente telestroke program increases use of clot-dissolving treatment for stroke patients

Kaiser Permanente telestroke program increases use of clot-dissolving treatment for stroke patients

The use of a life-saving clot-dissolving treatment for patients with acute ischemic stroke increased by 73 percent following the implementation of a Kaiser Permanente telestroke program, according to a study published today in The Permanente Journal. [More]
CVS Health to make opioid overdose-reversing drug more affordable for patients without insurance

CVS Health to make opioid overdose-reversing drug more affordable for patients without insurance

CVS Health and Adapt Pharma today announced a new partnership that will make the opioid overdose-reversing drug NARCAN (Naloxone HCl) Nasal Spray more affordable for patients without insurance at CVS Pharmacy locations. [More]
USPTO grants key patent for Quark Pharmaceuticals' QPI-1007 ocular neuroprotectant

USPTO grants key patent for Quark Pharmaceuticals' QPI-1007 ocular neuroprotectant

Quark Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office has granted a key patent covering the treatment of patients suffering from non-arteritic anterior ischemic optic neuropathy ("NAION") with the Company's ocular neuroprotectant QPI-1007. [More]
Researchers identify key immune differences that could help in development of effective HIV vaccine

Researchers identify key immune differences that could help in development of effective HIV vaccine

One of the main mysteries confounding development of an HIV vaccine is why some people infected with the virus make the desired antibodies after several years, but a vaccine can't seem to induce the same response. [More]
Vaccination against single strain could confer protection against diverse Zika virus infections

Vaccination against single strain could confer protection against diverse Zika virus infections

Vaccination against a single strain of Zika virus should be sufficient to protect against genetically diverse strains of the virus, according to a study conducted by investigators from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health; Washington University in St. Louis; and Emory University in Atlanta. [More]
University of Utah investigators receive $25 million grant to improve clinical research

University of Utah investigators receive $25 million grant to improve clinical research

Investigators at the University of Utah School of Medicine's Data Coordinating Center have been awarded a seven-year, $25 million grant from the National Center for Advancing Translational Sciences of the National Institutes of Health, to form one of three Trial Innovation Centers to improve clinical research. [More]
Convenience of buying medicine online does not outweigh risks, says expert

Convenience of buying medicine online does not outweigh risks, says expert

With the rise of on-demand delivery, prescription medicine joins the countless list of items that can be ordered online with the click of a button. [More]
World's largest public-private partnership focuses on tackling antibiotic resistance

World's largest public-private partnership focuses on tackling antibiotic resistance

The U.S. Department of Health and Human Services, the Wellcome Trust of London, the AMR Centre of Alderley Park, Cheshire in the United Kingdom and Boston University School of Law today announced the establishment of one of the world's largest public-private partnerships focused on tackling antibiotic resistance, an emerging modern threat to public health worldwide. [More]
Majority of American adults use prescription drugs inappropriately and dangerously

Majority of American adults use prescription drugs inappropriately and dangerously

The majority of American adults taking opioids and other commonly prescribed medications use them in ways that put their health at risk, including potentially dangerous combinations with other drugs, according to a new study from Quest Diagnostics, the world’s leading provider of diagnostic information services. [More]
Research could help clinicians identify patients who may benefit from targeted therapy for liver cancer

Research could help clinicians identify patients who may benefit from targeted therapy for liver cancer

New research from Roswell Park Cancer Institute offers clinicians treating patients with advanced liver cancer a way of determining which patients may benefit most from the targeted therapy sorafenib. [More]
MIT researchers develop portable device to manufacture biopharmaceuticals on demand

MIT researchers develop portable device to manufacture biopharmaceuticals on demand

For medics on the battlefield and doctors in remote or developing parts of the world, getting rapid access to the drugs needed to treat patients can be challenging. [More]
Researchers identify reason why antidepressants take so long to work

Researchers identify reason why antidepressants take so long to work

An episode of major depression can be crippling, impairing the ability to sleep, work, or eat. In severe cases, the mood disorder can lead to suicide. But the drugs available to treat depression, which can affect one in six Americans in their lifetime, can take weeks or even months to start working. [More]
UAB researchers uncover vital mechanism for L-DOPA-induced-dyskinesia

UAB researchers uncover vital mechanism for L-DOPA-induced-dyskinesia

Though the drug levodopa can dramatically improve Parkinson's disease symptoms, within five years one-half of the patients using L-DOPA develop an irreversible condition -- involuntary repetitive, rapid and jerky movements. [More]
New study to examine genomics of anti-platelet therapy after coronary interventions

New study to examine genomics of anti-platelet therapy after coronary interventions

Which antiplatelet medication is best after a coronary stent? The Tailored Antiplatelet Therapy to Lessen Outcomes After Percutaneous Coronary Intervention (TAILOR-PCI) Study examines whether prescribing heart medication based on a patient's CYP2C19 genotype will help prevent heart attack, stroke, unstable angina, and cardiovascular death in patients who undergo percutaneous coronary intervention (PCI), commonly called angioplasty. [More]
Discovery of pain paradox paves way to new methods of pain control

Discovery of pain paradox paves way to new methods of pain control

A natural substance known to activate pain in the central nervous system has been found to have the opposite effect in other parts of the body, potentially paving the way to new methods of pain control. [More]
Updated AAN guidelines state closure not recommended for individuals with stroke and heart defect

Updated AAN guidelines state closure not recommended for individuals with stroke and heart defect

An updated recommendation from the American Academy of Neurology states that catheter-based closure should not be routinely recommended for people who have had a stroke and also have a heart defect called a patent foramen ovale (PFO), a channel between the top two chambers in the heart. [More]
FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes. [More]
Resveratrol may be clinically beneficial to people with Alzheimer's disease

Resveratrol may be clinically beneficial to people with Alzheimer's disease

Resveratrol, given to Alzheimer's patients, appears to restore the integrity of the blood-brain barrier, reducing the ability of harmful immune molecules secreted by immune cells to infiltrate from the body into brain tissues, say researchers at Georgetown University Medical Center. [More]
Researchers discover two plant-derived compounds with potential for fighting inflammation and pain

Researchers discover two plant-derived compounds with potential for fighting inflammation and pain

New research reveals that two specific plant-derived compounds may be effective for fighting inflammation and pain. The findings are published in the British Journal of Pharmacology. [More]
Advertisement
Advertisement